Literature DB >> 7933087

Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.

A Schmitt1, J B Harry, B Rapp, F O Wettstein, T Iftner.   

Abstract

A comparative analysis of different properties of the E6 and E7 proteins of high-risk and low-risk cutaneous papillomaviruses was performed. The corresponding genomic regions of human papillomavirus types 1 and 8 (HPV1 and HPV8) and of the cottontail rabbit papillomavirus (CRPV) were cloned into the eucaryotic expression vector pZipNeo-SV(X)-1 and into vectors for in vitro transcription and translation. With the help of these vectors, the individual proteins were investigated for their ability to transform C127 and NIH 3T3 rodent fibroblasts, bind the Rb protein in vitro, transactivate the adenovirus E2 promoter, and cooperate in the immortalization of primary human keratinocytes. Expression vectors for HPV16 E6 and E7 were used as a positive control. A highly transformed phenotype could be observed with rodent cell lines expressing HPV8 E6, HPV16 E6 and E7, and, surprisingly, HPV1 E7. In contrast, no transformation was detected with CRPV long E6 and HPV8 E7, whereas cells expressing HPV1 E6 and CRPV short E6 exhibited a weakly transformed phenotype. Although neither CRPV E6 nor CRPV E7 caused morphological transformation of C127 cells, CRPV E6 was able to induce anchorage-independent growth in both rodent cell lines, whereas CRPV E7 led to high cloning efficiencies only in NIH 3T3 cells. The in vitro Rb-binding affinities relative to that of HPV 16 E7 were 66% for HPV1 E7, 34% for HPV8 E7, and 11% for CRPV E7. In spite of its high Rb-binding affinity, HPV1 E7 did not trans activate the adenovirus E2 promoter, whereas HPV8 E7 and CRPV E7 showed low activities. Complementation studies in primary human keratinocytes revealed a weak immortalizing potential for HPV8 E7 and indicated a low degree of cooperativity between CRPV E7 and CRPV or HPV16 E6.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933087      PMCID: PMC237142     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  In vitro expressed HPV 8 E6 protein does not bind p53.

Authors:  G Steger; H Pfister
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

3.  The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein.

Authors:  E W Wu; K E Clemens; D V Heck; K Münger
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

Review 4.  Human papillomaviruses and skin cancer.

Authors:  H Pfister
Journal:  Semin Cancer Biol       Date:  1992-10       Impact factor: 15.707

5.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

6.  Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.

Authors:  K M Haskell; G A Vuocolo; D Defeo-Jones; R E Jones; M Ivey-Hoyle
Journal:  J Gen Virol       Date:  1993-01       Impact factor: 3.891

7.  Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix.

Authors:  S P Wilczynski; M Oft; N Cook; S Y Liao; T Iftner
Journal:  Hum Pathol       Date:  1993-01       Impact factor: 3.466

8.  HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A.

Authors:  M Tommasino; J P Adamczewski; F Carlotti; C F Barth; R Manetti; M Contorni; F Cavalieri; T Hunt; L Crawford
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

9.  Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

Authors:  J K Schwarz; S H Devoto; E J Smith; S P Chellappan; L Jakoi; J R Nevins
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

10.  Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells.

Authors:  V Band; S Dalal; L Delmolino; E J Androphy
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  36 in total

1.  Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.

Authors:  F A Dick; E Sailhamer; N J Dyson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.

Authors:  S L Gonzalez; M Stremlau; X He; J R Basile; K Münger
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

Review 3.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

4.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Authors:  Benyue Zhang; Wei Chen; Ann Roman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

5.  Inhibition of human papillomavirus type 16 E7 phosphorylation by the S100 MRP-8/14 protein complex.

Authors:  Sharof Tugizov; Jennifer Berline; Rossana Herrera; Maria Elena Penaranda; Mayumi Nakagawa; Joel Palefsky
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

6.  Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

Authors:  B Rapp; A Pawellek; F Kraetzer; M Schaefer; C May; K Purdie; K Grassmann; T Iftner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Human papillomavirus type 8 E7 protein binds nuclear myosin 1c and downregulates the expression of pre-rRNA.

Authors:  Evelyn Oswald; Eileen Reinz; Renate Voit; François Aubin; Angel Alonso; Eeva Auvinen
Journal:  Virus Genes       Date:  2017-07-21       Impact factor: 2.332

8.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA.

Authors:  K Grassmann; B Rapp; H Maschek; K U Petry; T Iftner
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Transforming properties of the cottontail rabbit papillomavirus oncoproteins Le6 and SE6 and of the E8 protein.

Authors:  J B Harry; F O Wettstein
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

Review 10.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

Authors:  Raffaella Ghittoni; Rosita Accardi; Uzma Hasan; Tarik Gheit; Bakary Sylla; Massimo Tommasino
Journal:  Virus Genes       Date:  2009-10-17       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.